Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

241.00p
   
  • Change Today:
      12.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 262,085
  • Market Cap: £241.00m
  • RiskGrade: 125

Oxford Biomedica CEO John Dawson to step down

By Frank Prenesti

Date: Monday 17 Jan 2022

LONDON (ShareCast) - (Sharecast News) - Oxford Biomedica chief executive John Dawson said he was stepping down after 13 years at the helm of the Gene and cell therapy firm which helped develop a Covid-19 vaccine with AstraZeneca.
Dawson said he would "retire at the appropriate time".

"I believe this is the right time to start the transition to a new leader given the robustness of the senior team and company as a whole, which is undoubtedly stronger than ever before," he said in a statement.

Oxford Biomedica chairman Dr Roch Doliveux said it had started searching for Dawson's replacement to "lead the group through its next phase of growth".



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 241.00p
Change Today 12.50p
% Change 5.47 %
52 Week High 470.00
52 Week Low 166.80
Volume 262,085
Shares Issued 100.00m
Market Cap £241.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.41% above the market average32.41% above the market average32.41% above the market average32.41% above the market average32.41% above the market average
84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average
Price Trend
50.63% below the market average50.63% below the market average50.63% below the market average50.63% below the market average50.63% below the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Income Not Available
Growth
6.24% above the market average6.24% above the market average6.24% above the market average6.24% above the market average6.24% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 29-Apr-2024

Time Volume / Share Price
12:15 407 @ 241.50p
12:14 200 @ 241.50p
12:14 3 @ 242.50p
12:14 11 @ 240.50p
12:09 1,000 @ 241.24p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page